Cambridge, United Kingdom

Reenu Chopra


 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Milton Road, GB (2015)
  • Cambridge, GB (2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Reenu Chopra: Innovator in Pharmacological Advances**

Introduction

Reenu Chopra is an accomplished inventor based in Cambridge, GB, recognized for her significant contributions to pharmacology. With a keen focus on developing innovative compounds, she holds two patents that address critical health challenges, particularly in the realm of cancer treatment.

Latest Patents

Among her latest patents, Reenu has developed a compound characterized as the hydrochloride salt of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl)methyl sulfamate. This compound, along with its crystalline forms and solvates, showcases promising applications in pharmaceutical compositions. Specifically, it is intended for treating patients suffering from conditions that can be improved by inhibiting an E1 activating enzyme, particularly NAE, with implications for cancer therapy.

Career Highlights

Reenu Chopra's career spans numerous impactful positions in reputable companies, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. Her work reflects a commitment to advancing medical science through innovative drug development.

Collaborations

Throughout her career, Reenu has collaborated with esteemed colleagues such as Ian G. Armitage and Martin Ian Cooper. These collaborative efforts have facilitated the exchange of knowledge and enhanced the development of her patented inventions.

Conclusion

Reenu Chopra exemplifies the innovative spirit of modern inventors, combining her expertise in pharmacology with a strong focus on addressing pressing medical needs. Through her patents and collaborative work, she continues to pave the way for advancements that hold the potential to significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…